About HCP

HCP is a healthcare and life science investment banking firm created to advise small and middle-market healthcare companies. Its partners have completed more than 100 transactions in the healthcare sector with a value in excess of $1 billion. The majority of the transactions ranged in size from $10-100m. HCP advises healthcare and life science companies in identifying and structuring value-enhancing transactions primarily between the US and Europe. It focuses on business and assets divestitures, private equity and venture capital fund raising. HCP's competitive advantages include:

• a focused healthcare/life science and seasoned professional trans-Atlantic team.

• leveraging our European and US investment bankers' transaction experience.

• drawing upon our experience as senior members of European and US healthcare concerns to advise clients on corporate or project strategy.

• accepting equity participation in lieu of cash for advisory fees.

HCP focuses on the life sciences, pharmaceutical, medtech, and healthcare services.